Gamma retroviral vectors were used as delivery vectors in early clinical trials for gene therapy of IEIs, including ADA-SCID, X-linked SCID (X-SCID), Wiskott–Aldrich syndrome (WAS), and X-linked chronic granulomatous disease (X-CGD) (19–27). Here, ADA is linked to chronic granulomatous disease.